Filing Details
- Accession Number:
- 0001246360-15-003561
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-16 17:49:09
- Reporting Period:
- 2015-11-12
- Filing Date:
- 2015-11-16
- Accepted Time:
- 2015-11-16 17:49:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1333170 | Nxstage Medical Inc. | NXTM | Electromedical & Electrotherapeutic Apparatus (3845) | 043454702 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1341403 | Jr E Joseph Turk | 350 Merrimack Street Lawrence MA 01843 | President | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-11-12 | 342 | $2.11 | 108,305 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-11-12 | 2,213 | $9.96 | 110,518 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-11-12 | 4,055 | $20.44 | 106,463 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-11-12 | 342 | $0.00 | 342 | $2.11 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-11-12 | 2,213 | $0.00 | 2,213 | $9.96 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,174 | 2009-04-05 | 2016-03-04 | No | 4 | M | Direct |
21,522 | 2010-04-03 | 2017-03-02 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2015.